Atrial Fibrillation Ablation： Indications, Outcomes, Complications, and Future Directions
Atrial fibrillation （AF） is the most common type of cardiac arrhythmia which affects 33 million individuals worldwide？ It is associated with many adverse outcomes, including stroke, dementia, heart failure （HF）, and mortality. Based on a growing body of evidence illustrating its efficacy and safety,...
Saved in:
| Published in | Chinese medical journal Vol. 130; no. 16; pp. 1891 - 1893 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
China
Medknow Publications and Media Pvt. Ltd
20.08.2017
Lippincott Williams & Wilkins Ovid Technologies Medknow Publications & Media Pvt Ltd Wolters Kluwer |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Atrial fibrillation （AF） is the most common type of cardiac arrhythmia which affects 33 million individuals worldwide？ It is associated with many adverse outcomes, including stroke, dementia, heart failure （HF）, and mortality. Based on a growing body of evidence illustrating its efficacy and safety, catheter ablation （CA） has become an important treatment strategy for symptomatic AF. Most centers have progressively moved from performing paroxysmal AF to more complex long-standing persistent AF or patients with more comorbidities. |
|---|---|
| AbstractList | Indications and Patient Selection Multiple clinical trials have established the superiority of CA over antiarrhythmic drug therapy (AAD) for the maintenance of sinus rhythm and improvement of quality of life. The European Society of Cardiology (ESC) and the American Heart Association/American College of Cardiology/Heart Rhythm Society guidelines both recommend CA in patients with symptomatic recurrences of AF on AAD therapy (I, A for paroxysmal; IIa, C for persistent). [7] Assessment of CA for appropriate AF patients depends on multiple variables including AF type, left atrial (LA) size, the severity of symptoms, the presence of associated cardiovascular disease, and patient preference. A propensity-matched analysis of medically treated and ablated patients from the US Matket Scan Research Database Data (801 pairs matched) confirmed that CA was associated with a reduced risk of stroke/TIA compared with the control group (hazard ratio [HR]: 0.62, 95% confidential interval [CI]: 0.44-0.86). Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (NCT00911508) and Early Therapy of Atrial Fibrillation for Stroke Prevention Trial (NCT01288352), will provide new insights and establish whether AF ablation provides a significant reduction in stroke, death, and HF compared with standard management. Safety Improvement Initiative for Atrial Fibrillation Ablation With the rapid development of CA in China, the number of AF ablation performed in China has increasing from 11 cases in 1998 to more than 30,000 cases in 2016. The Chinese Heart Rhythm Society (CHRS) put forward the "AF catheter ablation safety improvement initiative," and put "Restore normal rhythm with doubled safety" as this year's conference... Atrial fibrillation （AF） is the most common type of cardiac arrhythmia which affects 33 million individuals worldwide？ It is associated with many adverse outcomes, including stroke, dementia, heart failure （HF）, and mortality. Based on a growing body of evidence illustrating its efficacy and safety, catheter ablation （CA） has become an important treatment strategy for symptomatic AF. Most centers have progressively moved from performing paroxysmal AF to more complex long-standing persistent AF or patients with more comorbidities. |
| Audience | Academic |
| Author | Xue-Yuan Guo Chang-Sheng Ma |
| AuthorAffiliation | Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China |
| AuthorAffiliation_xml | – name: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China |
| Author_xml | – sequence: 1 givenname: Xue-Yuan surname: Guo fullname: Guo, Xue-Yuan organization: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China – sequence: 2 givenname: Chang-Sheng surname: Ma fullname: Ma, Chang-Sheng organization: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28776538$$D View this record in MEDLINE/PubMed |
| BookMark | eNptksuO0zAUhi00iOkM7FmhCCTEghbb8SXeIFWFQqWRZgMrFpZvaV0ldsdJkHgVnoV34hVw2tKZIpyFT875zm_n5L8CFyEGB8BzBGcEwfIdLBmbMiHEDCMkIHwEJpgSPKWMoAswOZUvwVXXbSHElHL2BFziinNGy2oCvs375FVTLL1OvmlU72Mo5voQ_P71s1gF683-rXtb3A69ia3L0SK2u-a-oIItlkM_JFd88MmZffopeFyrpnPPjvs1-Lr8-GXxeXpz-2m1mN9MDcWsn2pLNEFKYQqdRg5WFlleKiJgrZlR-aKCEa0ZhtgqCLkxNVIOCmdrqrE15TVYHXRtVFu5S75V6YeMyst9Iqa1VKn3pnESVgS5GkHtdE0MLZVmVghtMBEWCYay1vuD1m7QrbPGhT6p5kz0vBL8Rq7jd0nzQhhmgTdHgRTvBtf1svWdcXm0wcWhk0hgxiqKiMjoq3_QbRxSyKMaKUo4Kzm_p9Yqf4APdcznmlFUzokQPIvx8d6z_1D5sa71Jrum9jl_1vD6QcPGqabfdLEZ9n_uHIQH0KTYdcnVp2EgKEcXytFmcrSZPLgwt7x4OMRTw1_bZeDlUXMTw_rOh_WJYbyEkGAmyj-kweS- |
| Cites_doi | 10.1016/j.jacc.2009.02.022 10.1111/j.1540-8167.2011.02010.x 10.1016/S0140-6736(16)31277-6 10.1111/jce.12849 10.1056/NEJMoa1113566 10.1016/j.jacc.2014.03.022 10.1161/CIRCOUTCOMES.111.963108 10.1161/CIRCULATIONAHA.113.005119 10.1093/eurheartj/eht194 10.1016/j.hrthm.2014.09.049 10.1093/eurheartj/ehw087 10.1001/jama.2014.3 10.1016/j.jacc.2009.02.024 10.1016/j.jacc.2012.04.060 10.1093/eurheartj/ehw210 10.1161/CIRCULATIONAHA.115.019406 10.1001/jama.2014.467 10.1016/j.cjca.2013.07.679 10.1161/CIRCULATIONAHA.113.003862 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2017 Medknow Publications and Media Pvt. Ltd. Copyright Medknow Publications & Media Pvt. Ltd. Aug 20, 2017 Copyright: © 2017 Chinese Medical Journal 2017 |
| Copyright_xml | – notice: COPYRIGHT 2017 Medknow Publications and Media Pvt. Ltd. – notice: Copyright Medknow Publications & Media Pvt. Ltd. Aug 20, 2017 – notice: Copyright: © 2017 Chinese Medical Journal 2017 |
| DBID | 2RA 92L CQIGP W91 ~WA NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.4103/0366-6999.211900 |
| DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 PubMed CrossRef ProQuest Central (Corporate) Health Medical collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Publicly Available Content database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection (Proquest) url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Atrial Fibrillation Ablation： Indications, Outcomes, Complications, and Future Directions |
| EISSN | 2542-5641 |
| EndPage | 1893 |
| ExternalDocumentID | oai_doaj_org_article_0841ef10bebf4c53ab6d99bc249d1961 A499768571 10_4103_0366_6999_211900 28776538 673004269 |
| Genre | Editorial Commentary |
| GroupedDBID | --- -05 -0E -SE -S~ .55 .GJ 29B 2B. 2C~ 2RA 2WC 3V. 40I 53G 5GY 5RE 5VR 5VS 6J9 7X7 88E 8FI 8FJ 92F 92I 92L 92M 93N 93R 9D9 9DE AAHPQ AASCR ABASU ABCQX ABDIG ABUWG ABVCZ ABXLX ACGFO ACGFS ACILI ADGGA ADHPY ADPDF ADRAZ AENEX AFDTB AFKRA AFUIB AHMBA AHVBC AINUH AJIOK AJNWD ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI ANFDX AOHHW BENPR BPHCQ BVXVI C1A CAJEE CAJUS CCEZO CCPQU CHBEP CIEJG CQIGP CW9 DIK DIWNM EBS EEVPB EJD F5P FA0 FCALG FRP FYUFA GNXGY GQDEL GROUPED_DOAJ GX1 HLJTE HMCUK HYE IAO IHR IHW IKREB INH INR IPNFZ ITC JUIAU KQ8 L7B M1P M48 OK1 OPUJH OVD OVDNE OVEED OXXIT P2P P6G PIMPY PQQKQ PROAC PSQYO PV9 Q-- Q-4 R-E RIG RLZ RNS RPM RT5 RZL S.. T8U TCJ TEORI TGQ TR2 TSPGW U1F U1G U5E U5O UKHRP W2D W91 WFFXF X7J X7M XSB ZA5 ZGI ZXP ~WA 0R~ AAAAV AAIQE ACXJB AHQNM AJZMW ALIPV BQLVK H13 NPM AAYXX CITATION 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c526t-bd4b41aa250eb1e08d1d73a490fb6ca765964bb6202da007ccf1ae09edf5b2dc3 |
| IEDL.DBID | RPM |
| ISSN | 0366-6999 |
| IngestDate | Tue Oct 22 14:58:33 EDT 2024 Tue Sep 17 21:22:49 EDT 2024 Fri Oct 25 03:49:41 EDT 2024 Thu Oct 10 20:16:08 EDT 2024 Thu Feb 22 23:54:00 EST 2024 Fri Feb 02 04:17:17 EST 2024 Tue Aug 20 22:14:01 EDT 2024 Fri Aug 23 00:38:05 EDT 2024 Wed Oct 16 00:57:22 EDT 2024 Wed Feb 14 09:57:29 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 16 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c526t-bd4b41aa250eb1e08d1d73a490fb6ca765964bb6202da007ccf1ae09edf5b2dc3 |
| Notes | Atrial fibrillation （AF） is the most common type of cardiac arrhythmia which affects 33 million individuals worldwide？ It is associated with many adverse outcomes, including stroke, dementia, heart failure （HF）, and mortality. Based on a growing body of evidence illustrating its efficacy and safety, catheter ablation （CA） has become an important treatment strategy for symptomatic AF. Most centers have progressively moved from performing paroxysmal AF to more complex long-standing persistent AF or patients with more comorbidities. 11-2154/R Atrial Fibrillation; Catheter Ablation; Complications; Indications; Ovtcomes SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555120/ |
| PMID | 28776538 |
| PQID | 1925476377 |
| PQPubID | 2042885 |
| PageCount | 3 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_0841ef10bebf4c53ab6d99bc249d1961 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5555120 proquest_miscellaneous_1926685149 proquest_journals_1925476377 gale_infotracmisc_A499768571 gale_infotracacademiconefile_A499768571 gale_healthsolutions_A499768571 crossref_primary_10_4103_0366_6999_211900 pubmed_primary_28776538 chongqing_primary_673004269 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-08-20 |
| PublicationDateYYYYMMDD | 2017-08-20 |
| PublicationDate_xml | – month: 08 year: 2017 text: 2017-08-20 day: 20 |
| PublicationDecade | 2010 |
| PublicationPlace | China |
| PublicationPlace_xml | – name: China – name: Baltimore – name: India |
| PublicationTitle | Chinese medical journal |
| PublicationTitleAlternate | Chinese Medical Journal |
| PublicationYear | 2017 |
| Publisher | Medknow Publications and Media Pvt. Ltd Lippincott Williams & Wilkins Ovid Technologies Medknow Publications & Media Pvt Ltd Wolters Kluwer |
| Publisher_xml | – name: Medknow Publications and Media Pvt. Ltd – name: Lippincott Williams & Wilkins Ovid Technologies – name: Medknow Publications & Media Pvt Ltd – name: Wolters Kluwer |
| References | 27567408 - Eur Heart J. 2016 Oct 7;37(38):2893-2962 27560278 - Lancet. 2016 Aug 20;388(10046):829-40 23761394 - Eur Heart J. 2013 Sep;34(35):2731-8 21332861 - J Cardiovasc Electrophysiol. 2011 Jul;22(7):729-38 24061087 - Circulation. 2013 Nov 5;128(19):2104-12 19422988 - J Am Coll Cardiol. 2009 May 12;53(19):1804-6 26443666 - J Cardiovasc Electrophysiol. 2016 Feb;27(2):141-6 24549549 - JAMA. 2014 Feb 19;311(7):692-700 24496537 - JAMA. 2014 Feb 5;311(5):498-506 22373904 - Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):171-81 28104790 - Eur Heart J. 2017 May 1;38(17 ):1303-1316 23094720 - N Engl J Med. 2012 Oct 25;367(17):1587-95 19422987 - J Am Coll Cardiol. 2009 May 12;53(19):1798-803 25257091 - Heart Rhythm. 2015 Jan;12(1):44-51 24685669 - J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76 24074971 - Can J Cardiol. 2013 Oct;29(10):1194-202 26984861 - Eur Heart J. 2016 Aug;37(31):2478-87 24345399 - Circulation. 2014 Feb 25;129(8):837-47 23062545 - J Am Coll Cardiol. 2012 Nov 6;60(19):1921-9 27029350 - Circulation. 2016 Apr 26;133(17 ):1637-44 Bunch (R9-1-20210129) 2016; 27 Chugh (R1-1-20210129) 2014; 129 Parkash (R3-1-20210129) 2011; 22 Arbelo (R19-1-20210129) 2017; 38 Deshmukh (R20-1-20210129) 2013; 128 Friberg (R15-1-20210129) 2016; 37 Cappato (R16-1-20210129) 2009; 53 Tilz (R7-1-20210129) 2012; 60 Kirchhof (R2-1-20210129) 2016; 37 Cosedis Nielsen (R5-1-20210129) 2012; 367 Kottkamp (R11-1-20210129) 2013; 34 Marrouche (R12-1-20210129) 2014; 311 Reynolds (R14-1-20210129) 2012; 5 Piccini (R17-1-20210129) 2016; 388 Belhassen (R18-1-20210129) 2009; 53 Di Biase (R10-1-20210129) 2016; 133 January (R4-1-20210129) 2014; 64 Nademanee (R8-1-20210129) 2015; 12 Morillo (R6-1-20210129) 2014; 311 Han (R13-1-20210129) 2013; 29 |
| References_xml | – volume: 38 start-page: 1303 year: 2017 ident: R19-1-20210129 article-title: Contemporary management of patients undergoing atrial fibrillation ablation: In-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry publication-title: Eur Heart J contributor: fullname: Arbelo – volume: 53 start-page: 1798 year: 2009 ident: R16-1-20210129 article-title: Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.02.022 contributor: fullname: Cappato – volume: 22 start-page: 729 year: 2011 ident: R3-1-20210129 article-title: Approach to the catheter ablation technique of paroxysmal and persistent atrial fibrillation: A meta-analysis of the randomized controlled trials publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2011.02010.x contributor: fullname: Parkash – volume: 388 start-page: 829 year: 2016 ident: R17-1-20210129 article-title: Rhythm control in atrial fibrillation publication-title: Lancet doi: 10.1016/S0140-6736(16)31277-6 contributor: fullname: Piccini – volume: 27 start-page: 141 year: 2016 ident: R9-1-20210129 article-title: The impact of age on 5-year outcomes after atrial fibrillation catheter ablation publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.12849 contributor: fullname: Bunch – volume: 367 start-page: 1587 year: 2012 ident: R5-1-20210129 article-title: Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1113566 contributor: fullname: Cosedis Nielsen – volume: 64 start-page: e1 year: 2014 ident: R4-1-20210129 article-title: 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.03.022 contributor: fullname: January – volume: 5 start-page: 171 year: 2012 ident: R14-1-20210129 article-title: Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: Results of a propensity-matched analysis publication-title: Circ Cardiovasc Qual Outcomes doi: 10.1161/CIRCOUTCOMES.111.963108 contributor: fullname: Reynolds – volume: 129 start-page: 837 year: 2014 ident: R1-1-20210129 article-title: Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.005119 contributor: fullname: Chugh – volume: 34 start-page: 2731 year: 2013 ident: R11-1-20210129 article-title: Human atrial fibrillation substrate: Towards a specific fibrotic atrial cardiomyopathy publication-title: Eur Heart J doi: 10.1093/eurheartj/eht194 contributor: fullname: Kottkamp – volume: 12 start-page: 44 year: 2015 ident: R8-1-20210129 article-title: Benefits and risks of catheter ablation in elderly patients with atrial fibrillation publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2014.09.049 contributor: fullname: Nademanee – volume: 37 start-page: 2478 year: 2016 ident: R15-1-20210129 article-title: Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: Data from Swedish health registries publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw087 contributor: fullname: Friberg – volume: 311 start-page: 498 year: 2014 ident: R12-1-20210129 article-title: Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: The DECAAF study publication-title: JAMA doi: 10.1001/jama.2014.3 contributor: fullname: Marrouche – volume: 53 start-page: 1804 year: 2009 ident: R18-1-20210129 article-title: A 1 per 1,000 mortality rate after catheter ablation of atrial fibrillation: An acceptable risk? publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.02.024 contributor: fullname: Belhassen – volume: 60 start-page: 1921 year: 2012 ident: R7-1-20210129 article-title: Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.04.060 contributor: fullname: Tilz – volume: 37 start-page: 2893 year: 2016 ident: R2-1-20210129 article-title: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw210 contributor: fullname: Kirchhof – volume: 133 start-page: 1637 year: 2016 ident: R10-1-20210129 article-title: Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: Results from the AATAC Multicenter Randomized Trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.019406 contributor: fullname: Di Biase – volume: 311 start-page: 692 year: 2014 ident: R6-1-20210129 article-title: Radiofrequency ablation vs. antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): A randomized trial publication-title: JAMA doi: 10.1001/jama.2014.467 contributor: fullname: Morillo – volume: 29 start-page: 1194 year: 2013 ident: R13-1-20210129 article-title: Value of magnetic resonance imaging in guiding atrial fibrillation management publication-title: Can J Cardiol doi: 10.1016/j.cjca.2013.07.679 contributor: fullname: Han – volume: 128 start-page: 2104 year: 2013 ident: R20-1-20210129 article-title: In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: Analysis of 93 801 procedures publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.113.003862 contributor: fullname: Deshmukh |
| SSID | ssj0025576 |
| Score | 2.199521 |
| Snippet | Atrial fibrillation （AF） is the most common type of cardiac arrhythmia which affects 33 million individuals worldwide？ It is associated with many adverse... Indications and Patient Selection Multiple clinical trials have established the superiority of CA over antiarrhythmic drug therapy (AAD) for the maintenance of... |
| SourceID | doaj pubmedcentral proquest gale crossref pubmed chongqing |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 1891 |
| SubjectTerms | Ablation (Surgery) Atrial fibrillation Atrial Fibrillation; Catheter Ablation; Complications; Indications; Outcomes Cardiac arrhythmia Care and treatment Catheters Complications and side effects Mortality NMR Nuclear magnetic resonance Stroke 不良后果 并发症 心力衰竭 心律失常 心房 死亡率 适应症 颤动 |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELZQD8AF8WZpASMhIaQu9e76EfcWKqKCBFyoVE6Wn1Cp2vJI_j8ztrPKqgcu5LSyJ1l5vvF4vng8JuQVbi0loFatGrhruWa-dZg0LiFaFirxLqWc5ftZnp7xj-fifOeqL8wJK-WBi-KO2IJ3MXXMRZe4F4N1MmjtPNCGANZTiA_TWzJVqZYQqu5SSnit1mWDkndsOJra3mJxMzzZdgsczfj9FywVs8Up1_C_7ql3lqp5GuXOurS6S-7UgJIuy0DukRtxvE9ufqpb5g_It2W-mIOuMLf_smS-0aUrD8f0wxi2_9od0i-bNRhghKeT3UzzQ2rHQFe5-gitPhKaH5Kz1fuvJ6dtvU-h9aKX69YF7nhnLUQ94KEjW4QuqMECQMlJb5UUWnLnZM_6YCF28D51NjIdQxKuD354RPbGqzE-ITTJFGzUyorEeWLBcXCcEFtFFpiyw9CQ_Ump5mepm4EpZJmy6Ya82ap56gQygvAYhMcgPKbA05B3iMMkh-WwcwMYialGYv5lJA15gSiacrZ0mtRmCXwP-JZQIPE6S-C0BjC9racTYLhYIGsmeTCThOno591bSzHVHfwxEEYLDp5cqYa8nLrxm5jiNsarTZaR8AvAWBvyuBjWNGigtYDOsGiImpncTCvznvHiRy4WLuDT9ezp_1DjPrndY1TD0LkekL317018BjHZ2j3P0-8vsuQwyQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Health Medical collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEB_0BPVF_LbeqRUEEa53aZuPrS-yHi6noL54cD6FfJ6CdO9j9_93Js32tgjuU0mm2zYz88tMZjIBeEOhpYiuVaVabiveMVdZShqXaC0LFXkdY8ry_SaPT_iXU3GaF9yuclrlBhMTUPulozXyQ7REBEdlUOrD-UVFp0ZRdDUfoXETbtUNkyTV6vTa4RJC5VilxId33RCm5DVrD8e2AypxRvvb7iDc9GcXOGFMpqhUyf9fvN6asKbJlFuz0-I-3MtmZTkf5OAB3Aj9Q7j9NQfOH8HPeTqeo1xQhv-fIf-tnNvh4n35ufebtbv98vt6hUMS8OpoO998vzS9LxepBkmZkRKbH8PJ4tOPo-Mqn6pQOdHIVWU9t7w2Bm0fxOnAZr72qjXIpmilM0qKTnJrZcMab9CCcC7WJrAu-Chs4137BHb6ZR-eQRll9CZ0yojIeWTecoRPtLAC80yZti1gdxxUfT5Uz6BEsuS4dQW82wzz2IkuCbFHE3s0sUcP7CngI_FhpKOi2KlheXmms45pNuN1iDWzwUbuRGus9F1nHXqYHoGmLuAVcVEPO0xH1dZz9PrQ6xIKKd4mClJuZKYzeY8Cfi6VyZpQ7k0oUSndtHsjKTqDwpW-FuECXo_ddCcluvVhuU40Ev8B_dYCng6CNX40OrfInXZWgJqI3GRUpj3971-pZLjAH2rI8_-_1i7cbchqYQSee7CzulyHF2hzrezLpFh_ATvjJ-Y priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals (Open Access) dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3da9RAEF-kgvpS_Da2agRBhObcJPtx6YucxaMK6osH9WnZz7ZQcu15B_rfd2Y3iReseQrZyXKZmZ39zc3HEvIGQ0sBXKtC1swUrKG2MJg0LgAtcxlYGULM8v0mjhfsywk_-Vse3THw142uHZ4ntVhdTH5f_fkACx7w64SVtH4PRljA5E0zwXZlFBz42xUWAmEiHxtiCoCdZRe5TNQpaHnjDNgieCql4Fi2chd-Snt6BTvJaO-KLf7_NeRbO9k4y3Jr25rfJ7sd3sxnSUEekFu-fUjufO0i6o_Iz1k8tyOfY-r_RUqMy2cm3Rzmn1vX_6l3kH_frEE_PdwdbSeiH-S6dfk8NifJOxMKjx-TxfzTj6PjojtuobC8EuvCOGZYqTWAIjDgnk5d6WStQX7BCKuBG41gxoiKVk4DtLA2lNrTxrvATeVs_YTstMvWPyN5EMFp30jNA2OBOsOAkwC9PHVU6rrOyN7AVHWZ2mpghln06JqMvOvZPAyCr4KSUigphZJSSVIZ-YhyGOiwW3Z8sFydqm7xKTplpQ8lNd4EZnmtjXBNYyy4ng4sUJmRVyhFlUpPhzWvZuAOgjvGJVC8jRSohyBMq7viBfhc7J81otwfUcJqtePhXlNUr-wKUDZnYOilzMjrYRjfxAy41i83kUbADODQZuRpUqzho3tdzYgcqdyIK-OR9vws9hLncJUVff7fOffIvQqRDEWDuk921quNfwE4bG1exuV1DcEYKlU priority: 102 providerName: Scholars Portal |
| Title | Atrial Fibrillation Ablation： Indications, Outcomes, Complications, and Future Directions |
| URI | http://lib.cqvip.com/qk/85656X/201716/673004269.html https://www.ncbi.nlm.nih.gov/pubmed/28776538 https://www.proquest.com/docview/1925476377 https://search.proquest.com/docview/1926685149 https://pubmed.ncbi.nlm.nih.gov/PMC5555120 https://doaj.org/article/0841ef10bebf4c53ab6d99bc249d1961 |
| Volume | 130 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9tQwJeEN-EjRIkJIS0tE7ij4a3rloZSB0TYlJ5ivw5Jm3ZGO3_z9lxoka8kYcosi9tcl--i38-A7z3U0sOU6tMlFRltCI6Ux40zjFaZsLR3LmA8j3lJ-f064qtdoB1a2ECaF-ry3FzdT1uLn8FbOXttZ50OLHJ2XLO8MgLMtmFXVTQLkWPWRZjIk5QcvzHqmrnJmlOyknfNvZ1zYjfBQ4TBsGZX53yAN1Nc_EbB4zBEBUq-f_rr7cGrCGYcmt0WjyGRzGsTGft4z-BHds8hfvLOHH-DH7OwvYc6cIj_K9a_Fs6U-3Fp_RLY7pvd4fpt80a1dDi1Xwbb36Yysaki1CDJI2eEpufw_ni-Mf8JIu7KmSaFXydKUMVzaXE2Af9tCVTkxtRShSTU1xL5EbFqVK8IIWRGEFo7XJpSWWNY6owunwBe81NY19B6rgz0lZCMkepI0ZR5CRGWJYYImRZJrDfM7W-batneCBZSNyqBD52bO47MSXxkqq9pGovqbqVVAJHXg49nS-KHRpu7i7qqBo1mdLcupwoqxzVrJSKm6pSGjNMg44mT-Ctl2LdrjDtTbueYdaHWRcTSPEhUHjjRmFqGdco4Ov6MlkDyoMBJRqlHnZ3mlJHp_CnxmCaUfTnQiTwru_2d3qgW2NvNoGG4y9g3prAy1ax-pfudDUBMVC5AVeGPWhBoWR4tJjX_33nPjwsfEBDvF89gL313ca-wXBsrUZohCsxgntHx6dn30fhowaeP69yPC_pdBTM8y9vajYF |
| link.rule.ids | 230,315,730,783,787,867,888,2109,2228,12069,21401,24331,27937,27938,31732,31733,33757,33758,43323,43818,53805,53807 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgSIwXxPfCNhYkJIS0MCfxR8PLVCaqDrbxsknlyfLnhoTSfbT_P3eOmzVCok-RfWkS393Pd77zmZAPGFoK4FoVsmamYA21hcGkcQHWMpeBlSHELN8zMb1g32d8lhbc7lJa5QoTI1C7ucU18gOwRDgDZZDy8PqmwFOjMLqajtB4SB5hHS6Uczm7d7g4lylWKeDhTdOFKVlJ64O-7TOWOMP9bZsAN-3lDUwYgykqVvL_F6_XJqxhMuXa7DR5Rp4mszIfd3LwnDzw7Qvy-DQFzl-SX-N4PEc-wQz_P13-Wz423cWX_Lh1q7W7_fzncgFD4uHqaD3ffD_XrcsnsQZJnpASml-Ri8m386NpkU5VKCyvxKIwjhlWag22D-C0pyNXOllrYFMwwmopeCOYMaKildNgQVgbSu1p413gpnK2fk022nnrt0geRHDaN1LzwFigzjCAT7CwPHVU6rrOyHY_qOq6q56BiWTRcWsy8mk1zH0nuCTIHoXsUcge1bEnI1-RDz0dFsWODfPbS5V0TNERK30oqfEmMMtrbYRrGmPBw3QANGVG9pCLqtth2qu2GoPXB14Xl0DxMVKgcgMzrU57FOBzsUzWgHJnQAlKaYfdK0lRCRTu1L0IZ-R93413YqJb6-fLSCPgH8BvzcibTrD6jwbnFrhTjzIiByI3GJVhT_v7KpYM5_ArK_r2_6-1Rzan56cn6uT47Mc2eVKhBUMRSHfIxuJ26XfB_lqYd1HJ_gIyQCrN |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFH6CIhUu7EtooUFCQkjNjJN4abgNA6MWaOmBSi0Xy2upaNOhzFz49Tw7iyZwa06R_ZLI9ue3xJ-fAV6HpSWPoVUmSqozWhGT6UAa5-gtM-Fp7n1k-R7w3SP66Zgdrxz1FUn7Rp-N6vOLUX32I3Ir5xdm3PHExof7U4ZXXpDx3PrxTbjFQtL0LlBvYy3GRLtMyfG7VdWsUNKclOO-bBSym5FwFhyGDYKzsEflNiqd-vQXmo2BoYr5_P_X2itma0ipXLFRs3vwvWtdQ035OVou9Mj8-Sfx47Wafx_utp5rOmlEHsANVz-E9f12bf4RnEziCSDpLGwiOG8odulENzfv0r3adr8Ht9OvywUi3eHddJXSvp2q2qazmOYkbZUxFj-Go9nHb9PdrD24ITOs4ItMW6pprhS6V2gKHNmxuRWlQiR4zY3Crq441ZoXpLAKnRRjfK4cqZz1TBfWlE9grb6s3TNIPfdWuUoo5in1xGqKw4ROnCOWCFWWCWz0IybnTYKOwFWLsWGVwNtuDPtKjHoCDGSAgQwwkA0MEngfBrmXC3m3Y8Hl1alsu1-SHZo7nxPttKeGlUpzW1XaYBBrUZflCWwFiMhmE2uvPeQEA0sM7JhAiTdRIugPRIpR7TYIbG7IxDWQ3BxI4rw3w-oOhrLVO78l-uuMoskQIoFXfXV4MnDpane5jDIc34ChcQJPG9T2je4mQgJigOdBrwxrEKUxK3mLyufXfnIL1g8_zOSXvYPPG3CnCO4TCVp8E9YWV0v3Ap2_hX4Zp_lf_oNVMg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Atrial+Fibrillation+Ablation%3A+Indications%2C+Outcomes%2C+Complications%2C+and+Future+Directions&rft.jtitle=Chinese+medical+journal&rft.au=Guo%2C+Xue-Yuan&rft.au=Ma%2C+Chang-Sheng&rft.date=2017-08-20&rft.issn=0366-6999&rft.volume=130&rft.issue=16&rft.spage=1891&rft_id=info:doi/10.4103%2F0366-6999.211900&rft_id=info%3Apmid%2F28776538&rft.externalDocID=28776538 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85656X%2F85656X.jpg |